Jennifer Klarer
Partner and Head of Cell & Gene Therapy at The Dedham Group with expertise in pricing and value for CGTs
Best podcasts with Jennifer Klarer
Ranked by the Snipd community
Feb 1, 2024 • 37min
Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.
Jennifer Klarer from The Dedham Group delves into pricing and value for CGTs, addressing misconceptions and solutions. Topics include time to treatment challenges, securing investment, and payer dynamics. Learn about the importance of early commercial planning and navigating evolving payment models for financial stability.
